Animal Health Market

Report Overview

The global animal health market was pegged at US$ 38.94 billion in 2021 and is expected to witness a CAGR of 9.8% during the forecast period from 2022 to 2030.

Market Fundamentals                                                                                          

Animal health includes procedures and practices for proper maintenance of the health of the animals with drugs, and animal feeds, diagnostics, and vaccines. Animals also suffer from various diseases just like humans, thus, require proper treatment from veterinarians. Improving the health and well-being of animals is a primary objective of the animal health market. This market includes products and services to enhance animal health and livestock productivity. These products and services include medicated drugs, vaccines, feeds, nutritional supplements, and many more. 

[734983]

Market Dynamics

The global animal health market is growing at a noticeable speed. This growth can be attributed to animal and foodborne diseases' increasing prevalence. Growing interaction with illnesses as a result of an increase in pet adoption for companionship is dispersing animal-borne diseases over the globe, thus, increasing demands for animal health. In addition, growing numbers of companion animals, a rise in the need for pet insurance, and rising income levels in industrialized nations are all contributing factors. Furthermore, increasing technological advancement for the diagnostics purpose of zoonotic diseases, growing approvals for novel products and drugs, and advancements in vaccines also contribute the market growth. Additionally, increasing government initiatives, growing company acquisitions, mergers, and rising animal health expenditure further help upsurge the market expansion. Challenges in the global animal health market are the lack of information accessible about the diseases that affect livestock or companion animals and the lack of research into the conditions that animals may contract.

Market Ecosystem

The global animal health market has been analyzed from four perspectives: product, animal type, end-user, and region. 

Animal Health Market by Product

[9875434]

Based on product, the global animal health market has been segmented into diagnostics, drugs, feed, and vaccines. The drug segment holds the largest revenue share in the market. The growth of this segment can be attributed to the rising prevalence of diseases in animals, increasing consumption of drugs for treatment purposes, and growing adoption of pharmaceuticals due to the increase in the ownership of companion animals. Furthermore, rising acquisition and collaboration can be considered significant factor contributing to this segment's overall growth.

While the diagnostics segment is expected to grow significantly owing to the rising prevalence of animal diseases and increasing animal health expenditure. Additionally, continuous approval of novel products, technological advancements, and increasing requirements for point-of-care diagnostics (such as pregnancy kits, blood glucose monitors, etc.) further contribute to the growth of this segment.

Animal Health Market by Animal Type

Based on the animal type, the global animal health market has been bifurcated into companion and farm animals. Farm animals dominate the segment with the most significant share in the global animal health market. This growth can be attributed to preserving the animals' health for food production, safeguarding public health, and maintaining the food supply; farmers use medications. Farmers that breed cattle, pigs, poultry, and other livestock produce high livestock production. Healthy cattle are utilized for meat production and dairy products supplied domestically and internationally. This benefits the different economies and provides consumers with wholesome, inexpensive food, raising the demand for healthy animals for consumption. The companion animal segment is also proliferating due to increasing demand for pet nurturing and pet-human bonds. 

Animal Health Market by End-user

Based on end-user, the animal health market has been segmented into animal care and rehabilitation centers, diagnostic centers, veterinary hospitals and clinics, and others. The veterinary hospital and clinics lead the segment with the largest revenue share. This attributes to the increasing prevalence of zoonotic diseases and the growing number of pet hospitals. Additionally, this segment provides a wide variety of diagnostic and therapeutic options, a high-impact growth driver for this market. At the same time, diagnostic centers hold the second largest market share due to the growing cases of animal diseases. Moreover, the market is also being driven by the development of molecular diagnostic tests (such as ELISA and PCR), which currently make up a sizable portion of the animal healthcare industry.

Animal Health Market by Region

Geographically, the animal health market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the market with the largest revenue share. The growth of the animal health market in this region can be attributed to various factors, including technological advancements, an increase in zoonotic diseases, and an increase in the number of pet owners in the nation. These factors have also allowed government animal welfare organizations to adopt various effective measures. With constant growth anticipated over the long term, Europe is predicted to hold the second position in this market. The market is expanding due to rising animal-based food consumption and stringent animal health laws.

Competitive Landscape

Some of the prominent players operating in the global animal health market are: 

• Intervet International B.V.
• Boehringer Ingelheim International GmbH
• Emergent BioSolutions Inc.
• Elanco Animal Health Incorporated
• Virbac
• Emergent BioSolutions Inc.
• Merck & Co. Inc.
• IDEXX Laboratories Inc.
• Zoetis Inc.
• Vetoquinol S.A.
• Ceva Santé Animale
• Televet

Strategic Developments

• In Aug 2021, Elanco closed its acquisition of Kindred Bioscience. The acquisition was made to strengthen the product portfolio and strategy to serve veterinarians' unmet medical needs. 
• In April 2021, Hester Biosciences launched a brand-new line of herbal products for livestock and poultry to complement its current product line and enhance the general welfare of animals.
• In Nov. 2019, Leading veterinary corporation Zoetis acquired the ZNLab, a full-service veterinary clinical reference laboratory firm. The acquisition expanded Zoetis’ product line in the diagnostic market.

Frequently Asked Questions About This Report